Sort
21,453 grants matching “tuberculosis”
Mycobacterium Tuberculosis (MTB) Quality Assessment Program (TBQA)
$1,674,843Gene Garrard Olinger · Midwest Research Institute · N01 · FY2024 · AI
United States Military HIV Research Program (MHRP) Clinical Trials Unit
$1,674,576Nelson Lee Michael · Walter Reed Army Institute Of Research · UM1 · FY2015 · AI
AIDS CLINICAL TRIALS UNIT
$1,672,194University Of Pennsylvania · U01 · FY2000 · AI
Immune Regulation in Mycobacterial and Fungal Infections
$1,671,700Daniel Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Host Defense Against HIV-related Pulmonary Infections
$1,671,641Judd E Shellito · Lsu Health Sciences Center · P01 · FY2013 · HL
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$1,670,904Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Exploring the impact of inflammaging on immune function during M. tb infection
$1,669,920Joanne Turner · Texas Biomedical Research Institute · P01 · FY2019 · AG
Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease
$1,669,694Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Malaria Transmission and the Impact of Control Efforts in Southern and Central Africa
$1,668,892William J Moss · Johns Hopkins University · U19 · FY2017 · AI
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$1,668,684Kathleen Moser · County/San Diego Health / Human Ser/Ag · U52 · FY2006 · PS
Integrated University of Puerto Rico Clinical Trials Unit
$1,667,675Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2014 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,667,113New York University School Of Medicine · U01 · FY2003 · AI
Host Determinants of TB Disease Progression
$1,664,165Alan A Aderem · Seattle Biomedical Research Institute · U19 · FY2014 · AI
RP1: Targeting Beclin 1 complexes for broad-spectrum anti-infective therapeutics
$1,663,905Tiffany Anne Reese · Ut Southwestern Medical Center · U19 · FY2021 · AI
National Resource For Advanced NMR Technology
$1,663,854Timothy A Cross · Florida State University · P41 · FY2017 · GM
INTEGRINS AND MODULAR SURFACE PROTEINS IN VASCULATURE
$1,660,699Immune Disease Institute, Inc. · P01 · FY2003 · HL
Immunoregulation /immune Recognition In Filarial/Nonfilarial Parasitic Infection
$1,660,073Thomas B. Nutman · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
A-Z Clinical Trials Unit
$1,659,641Paul A. Goepfert · University Of Alabama At Birmingham · UM1 · FY2024 · AI
Development of a second generation MDR-XDR TB assay
$1,656,910David Alland · Univ Of Med/Dent Of Nj-Nj Medical School · U01 · FY2012 · AI
Broad-Spectrum Antimicrobials Targeting the D-Alanine Pathway
$1,655,184Karen G. Anthony · L2 Diagnostics, Llc · U01 · FY2012 · AI
ADULT AIDS CLINICAL TRIALS UNIT
$1,655,127New York University School Of Medicine · U01 · FY2002 · AI
Exploring the impact of inflammaging on immune function during M. tb infection
$1,654,552Joanne Turner · Texas Biomedical Research Institute · P01 · FY2020 · AG
TUBERCULOSIS ELIMINATION AND LABORATORY
$1,654,499Sue Etkind · Ma St Executive Office Of Health & Human Services · U52 · FY2006 · PS
TUBERCULOSIS ELIMINATION AND LABORATORY PROGRAM FUNDING
$1,654,173Richard Stancil · Houston Department/Health/Human Srvs · U52 · FY2014 · PS
Molecular Analysis of Tuberculosis Immunity
$1,651,620William Robert Jacobs · Albert Einstein College Of Medicine · P01 · FY2013 · AI